Bio Rad Laboratories Inc
NYSE:BIO
Bio Rad Laboratories Inc
NYSE:BIO
Price:
300.97 USD
2.37%
Market Closed
Updated:
May 16, 2024
Bio Rad Laboratories Inc
Interest Income Expense
|
Bio Rad Laboratories Inc
Interest Income Expense Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bio Rad Laboratories Inc
NYSE:BIO
|
Interest Income Expense
-$769.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-30%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Interest Income Expense
-$542m
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-9%
|
|
|
Danaher Corp
NYSE:DHR
|
Interest Income Expense
-$366m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
-11%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Interest Income Expense
-$78.4m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-13%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Interest Income Expense
-$24m
|
CAGR 3-Years
28%
|
CAGR 5-Years
18%
|
CAGR 10-Years
14%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Interest Income Expense
-$636m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-18%
|
See Also
What is Bio Rad Laboratories Inc's Interest Income Expense?
Interest Income Expense
-769.1m
USD
-769.1m
USD
Based on the financial report for Mar 31, 2024, Bio Rad Laboratories Inc's Interest Income Expense amounts to -769.1m USD.
What is Bio Rad Laboratories Inc's Interest Income Expense growth rate?
Interest Income Expense CAGR 10Y
-30%
-30%
Over the last year, the Interest Income Expense growth was -21%.
You don't have any saved screeners yet
